Cover Image
市場調查報告書

亞太地區的感染疾病診斷市場未來展望

Asia-Pacific Infectious Diagnostics Market Outlook to 2021

出版商 GlobalData 商品編碼 348482
出版日期 內容資訊 英文 105 Pages
訂單完成後即時交付
價格
Back to Top
亞太地區的感染疾病診斷市場未來展望 Asia-Pacific Infectious Diagnostics Market Outlook to 2021
出版日期: 2015年10月05日 內容資訊: 英文 105 Pages
簡介

本報告提供亞太地區各國 (澳洲·中國·印度·日本·韓國) 的感染疾病診斷藥的市場相關分析,提供您地區整體市場規模趨勢預測 (以金額為準,過去·今後8年份) ,及各國層級之詳細趨勢,主要企業·流通管道的市場佔有率,主要開發中產品的目前臨床實驗情形,主要企業簡介,最新的市場動靜等相關之調查與考察。

第1章 目錄

第2章 簡介

  • 本報告概要
  • 免疫化學市場明細
  • 分析對象市場定義

第3章 亞太地區的感染疾病診斷藥市場

  • 市場收益額:總額 (總計15年份)
  • 市場收益額:不同分類的明細 (總計15年份)
  • 市場收益額的實際成果值:以金額為準 (過去8年份)
  • 市場收益額的預測值:以金額為準 (今後8年份)
  • 市場收益額佔有率:各企業

第4章 澳洲的感染疾病診斷藥市場

  • 市場收益額的實際成果值:以金額為準 (過去8年份)
  • 市場收益額的預測值:以金額為準 (今後8年份)
    • 迅速/POC (照護現場) 感染疾病診斷藥的市場趨勢 (過去·今後8年份)
  • 市場收益額佔有率:各流通管道
  • 市場收益額佔有率:各企業

第5章 中國的感染疾病診斷藥市場

第6章 印度的感染疾病診斷藥市場

第7章 日本的感染疾病診斷藥市場

第8章 韓國的感染疾病診斷藥市場

第9章 亞太地區的感染疾病診斷藥市場:主要企業概要

  • Abbott Laboratories
  • F. Hoffmann-La Roche Ltd.
  • Siemens Healthcare
  • Danaher Corporation
  • Transasia Bio-Medicals Ltd.
  • Qiagen N.V.
  • Bio-Rad Laboratories, Inc.
  • Alere Inc.
  • Becton, Dickinson and Company
  • bioMerieux S.A.
  • Hologic, Inc.
  • DiaSorin S.p.A

第10章 免疫化學市場開發中產品

第11章 近幾年趨勢

  • 來自企業的發表內容 (1件)
  • 公佈財報 (全6件)
  • 其他主要動向 (全2件)
  • 產品新聞 (1件)
  • 策略·產業計畫 (1件)

第12章 附錄

圖表一覽

目錄
Product Code: GDMECR0340DB

GlobalData's new report, "Asia-Pacific Infectious Diagnostics Market Outlook to 2021", provides key market data on the Asia-Pacific Infectious Diagnostics market. The report provides value, in millions of US dollars within market segments - Hepatitis Viruses, Retroviruses, Infectious Diagnostics Multiple Parameters Panels, Bacteriology, Nucleic Acid Testing Instruments, Other Virology, Infectious Diagnostics Rapid Tests & POC and Parasitology & Mycology.

The report also provides company shares and distribution shares data for the market category, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is available in the report.

Extensive interviews are conducted with industry experts to validate the market size, company share and distribution share data and analysis.

Scope

  • Infectious Diagnostics market includes Hepatitis Viruses, Retroviruses, Infectious Diagnostics Multiple Parameters Panels, Bacteriology, Nucleic Acid Testing Instruments, Other Virology, Infectious Diagnostics Rapid Tests & POC and Parasitology & Mycology.
  • Annualized market revenues (USD million) data for each of the market categories. Data is provided from 2007 to 2014 and forecast to 2021.
  • 2014 company shares and distribution shares data for Infectious Diagnostics market.
  • Global corporate-level profiles of key companies operating within the Asia-Pacific Infectious Diagnostics market.
  • Key players covered include Siemens Healthcare, F. Hoffmann-La Roche Ltd., Abbott Laboratories, Hologic, Inc., Qiagen N.V., Becton, Dickinson and Company, Danaher Corporation and Alere Inc..

Reasons to buy

  • Develop business strategies by identifying the key market segments poised for strong growth in the future.
  • Develop market-entry and market expansion strategies.
  • Design competition strategies by identifying who-stands-where in the market.
  • Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
  • What are the key distribution channels and what's the most preferred mode of product distribution - Identify, understand and capitalize.

Table of Contents

1. Table of Contents

  • 1.1. List of Tables
  • 1.2. List of Figures

2. Introduction

  • 2.1. What Is This Report About?
  • 2.2. Infectious Diagnostics Market Segmentation
  • 2.3. Definitions of Markets Covered in the Report

3. Infectious Diagnostics Market, Asia-Pacific

  • 3.1. Infectious Diagnostics Market, Asia-Pacific, Revenue ($m), 2007-2021
  • 3.2. Infectious Diagnostics Market, Asia-Pacific, Category Comparison by Revenue ($m), 2007-2021
  • 3.3. Infectious Diagnostics Market, Asia-Pacific, Revenue ($m), 2007-2014
  • 3.4. Infectious Diagnostics Market, Asia-Pacific, Revenue ($m), 2014-2021
  • 3.5. Infectious Diagnostics Market, Asia-Pacific, Company Share by Revenue ($m), 2014

4. Infectious Diagnostics Market, Australia

  • 4.1. Infectious Diagnostics Market, Australia, Revenue ($m), 2007-2014
  • 4.2. Infectious Diagnostics Market, Australia, Revenue ($m), 2014-2021
    • 4.2.1. Infectious Diagnostics Rapid Tests & POC Market, Australia, Revenue ($m), by Segment, 2007-2014
    • 4.2.2. Infectious Diagnostics Rapid Tests & POC Market, Australia, Revenue ($m), by Segment, 2014-2021
  • 4.3. Infectious Diagnostics Market, Australia, Distribution Share by Revenue ($m), 2013-2014
  • 4.4. Infectious Diagnostics Market, Australia, Company Share by Revenue ($m), 2014

5. Infectious Diagnostics Market, China

  • 5.1. Infectious Diagnostics Market, China, Revenue ($m), 2007-2014
  • 5.2. Infectious Diagnostics Market, China, Revenue ($m), 2014-2021
    • 5.2.1. Infectious Diagnostics Rapid Tests & POC Market, China, Revenue ($m), by Segment, 2007-2014
    • 5.2.2. Infectious Diagnostics Rapid Tests & POC Market, China, Revenue ($m), by Segment, 2014-2021
  • 5.3. Infectious Diagnostics Market, China, Distribution Share by Revenue ($m), 2013-2014
  • 5.4. Infectious Diagnostics Market, China, Company Share by Revenue ($m), 2014

6. Infectious Diagnostics Market, India

  • 6.1. Infectious Diagnostics Market, India, Revenue ($m), 2007-2014
  • 6.2. Infectious Diagnostics Market, India, Revenue ($m), 2014-2021
    • 6.2.1. Infectious Diagnostics Rapid Tests & POC Market, India, Revenue ($m), by Segment, 2007-2014
    • 6.2.2. Infectious Diagnostics Rapid Tests & POC Market, India, Revenue ($m), by Segment, 2014-2021
  • 6.3. Infectious Diagnostics Market, India, Distribution Share by Revenue ($m), 2013-2014
  • 6.4. Infectious Diagnostics Market, India, Company Share by Revenue ($m), 2014

7. Infectious Diagnostics Market, Japan

  • 7.1. Infectious Diagnostics Market, Japan, Revenue ($m), 2007-2014
  • 7.2. Infectious Diagnostics Market, Japan, Revenue ($m), 2014-2021
    • 7.2.1. Infectious Diagnostics Rapid Tests & POC Market, Japan, Revenue ($m), by Segment, 2007-2014
    • 7.2.2. Infectious Diagnostics Rapid Tests & POC Market, Japan, Revenue ($m), by Segment, 2014-2021
  • 7.3. Infectious Diagnostics Market, Japan, Distribution Share by Revenue ($m), 2013-2014
  • 7.4. Infectious Diagnostics Market, Japan, Company Share by Revenue ($m), 2014

8. Infectious Diagnostics Market, South Korea

  • 8.1. Infectious Diagnostics Market, South Korea, Revenue ($m), 2007-2014
  • 8.2. Infectious Diagnostics Market, South Korea, Revenue ($m), 2014-2021
    • 8.2.1. Infectious Diagnostics Rapid Tests & POC Market, South Korea, Revenue ($m), by Segment, 2007-2014
    • 8.2.2. Infectious Diagnostics Rapid Tests & POC Market, South Korea, Revenue ($m), by Segment, 2014-2021
  • 8.3. Infectious Diagnostics Market, South Korea, Distribution Share by Revenue ($m), 2013-2014
  • 8.4. Infectious Diagnostics Market, South Korea, Company Share by Revenue ($m), 2014

9. Overview of Key Companies in Asia-Pacific Infectious Diagnostics Market

  • 9.1. Abbott Laboratories
    • 9.1.1. Company Overview
  • 9.2. F. Hoffmann-La Roche Ltd.
    • 9.2.1. Company Overview
  • 9.3. Siemens Healthcare
    • 9.3.1. Company Overview
  • 9.4. Danaher Corporation
    • 9.4.1. Company Overview
  • 9.5. Transasia Bio-Medicals Ltd.
    • 9.5.1. Company Overview
  • 9.6. Qiagen N.V.
    • 9.6.1. Company Overview
  • 9.7. Bio-Rad Laboratories, Inc.
    • 9.7.1. Company Overview
  • 9.8. Alere Inc.
    • 9.8.1. Company Overview
  • 9.9. Becton, Dickinson and Company
    • 9.9.1. Company Overview
  • 9.10. bioMerieux S.A.
    • 9.10.1. Company Overview
  • 9.11. Hologic, Inc.
    • 9.11.1. Company Overview
  • 9.12. DiaSorin S.p.A
    • 9.12.1. Company Overview

10. Infectious Diagnostics Market Pipeline Products

11. Recent Developments

  • 11.1. Corporate Communications
    • 11.1.1. Dec 04, 2014: Neogen names COO
  • 11.2. Financial Announcements
    • 11.2.1. Jul 21, 2015: Neogen reports record revenues and earnings
    • 11.2.2. May 09, 2015: Shanghai MicroPort Orthopedics Hosts First SuperPath Online Symposium
    • 11.2.3. Mar 26, 2015: Neogen reports 13% increase in net income
    • 11.2.4. Mar 18, 2015: Blue Belt Technologies Announces First Navio Case Performed in Australia and First Navio-assisted GRU Unicompartmental Knee Replacement
    • 11.2.5. Dec 31, 2014: MicroPort Completes First Implantation of Reewarm18
    • 11.2.6. Dec 18, 2014: Neogen reports 26% increase in net income
  • 11.3. Other Significant Developments
    • 11.3.1. Jun 11, 2015: Lansen subsidiary signs a distribution agreement with Bio-Rad China and expands into the clinical diagnostic market in the PRC
    • 11.3.2. Nov 05, 2014: Bearing Analytics Changes Name To DATTUS, Opens Office In India
  • 11.4. Product News
    • 11.4.1. Nov 19, 2014: Seegene Receives US Patent for TOCE Technology
  • 11.5. Strategy And Business Planning
    • 11.5.1. May 19, 2015: QIAGEN opens new office in Kuala Lumpur as business expands in Malaysia

12. Appendix

  • 12.1. Research Methodology
    • 12.1.1. Coverage
    • 12.1.2. Secondary Research
    • 12.1.3. Primary Research
    • 12.1.4. Company Share Analysis
    • 12.1.5. Distribution Share Analysis
  • 12.2. GlobalData Consulting
  • 12.3. Contact Us
  • 12.4. Disclaimer

List of Tables

  • Table 1: Infectious Diagnostics Market, Cross Country Comparison, Asia-Pacific, Revenue ($m), USD Constant, 2007-2021
  • Table 2: Infectious Diagnostics Market, Asia-Pacific, Category Comparison by Revenue ($m), USD Constant, 2007-2021
  • Table 3: Infectious Diagnostics Market, Asia-Pacific, Revenue ($m), Historic, USD Constant, 2007-2014
  • Table 4: Infectious Diagnostics Market, Asia-Pacific, Revenue ($m), Forecast, USD Constant, 2014-2021
  • Table 5: Infectious Diagnostics Market, Asia-Pacific, Company Share by Revenue ($m), USD Constant, 2014
  • Table 6: Infectious Diagnostics Market, Australia, Revenue ($m), USD Constant, Historic, 2007-2014
  • Table 7: Infectious Diagnostics Market, Australia, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Table 8: Infectious Diagnostics Rapid Tests & POC Market, Australia, Revenue ($m), USD Constant, Historic, 2007-2014
  • Table 9: Infectious Diagnostics Rapid Tests & POC Market, Australia, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Table 10: Infectious Diagnostics Market, Australia, Distribution Share by Revenue ($m), USD Constant, 2013-2014
  • Table 11: Infectious Diagnostics Market, Australia, Company Share by Revenue ($m), USD Constant, 2014
  • Table 12: Infectious Diagnostics Market, China, Revenue ($m), USD Constant, Historic, 2007-2014
  • Table 13: Infectious Diagnostics Market, China, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Table 14: Infectious Diagnostics Rapid Tests & POC Market, China, Revenue ($m), USD Constant, Historic, 2007-2014
  • Table 15: Infectious Diagnostics Rapid Tests & POC Market, China, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Table 16: Infectious Diagnostics Market, China, Distribution Share by Revenue ($m), USD Constant, 2013-2014
  • Table 17: Infectious Diagnostics Market, China, Company Share by Revenue ($m), USD Constant, 2014
  • Table 18: Infectious Diagnostics Market, India, Revenue ($m), USD Constant, Historic, 2007-2014
  • Table 19: Infectious Diagnostics Market, India, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Table 20: Infectious Diagnostics Rapid Tests & POC Market, India, Revenue ($m), USD Constant, Historic, 2007-2014
  • Table 21: Infectious Diagnostics Rapid Tests & POC Market, India, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Table 22: Infectious Diagnostics Market, India, Distribution Share by Revenue ($m), USD Constant, 2013-2014
  • Table 23: Infectious Diagnostics Market, India, Company Share by Revenue ($m), USD Constant, 2014
  • Table 24: Infectious Diagnostics Market, Japan, Revenue ($m), USD Constant, Historic, 2007-2014
  • Table 25: Infectious Diagnostics Market, Japan, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Table 26: Infectious Diagnostics Rapid Tests & POC Market, Japan, Revenue ($m), USD Constant, Historic, 2007-2014
  • Table 27: Infectious Diagnostics Rapid Tests & POC Market, Japan, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Table 28: Infectious Diagnostics Market, Japan, Distribution Share by Revenue ($m), USD Constant, 2013-2014
  • Table 29: Infectious Diagnostics Market, Japan, Company Share by Revenue ($m), USD Constant, 2014
  • Table 30: Infectious Diagnostics Market, South Korea, Revenue ($m), USD Constant, Historic, 2007-2014
  • Table 31: Infectious Diagnostics Market, South Korea, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Table 32: Infectious Diagnostics Rapid Tests & POC Market, South Korea, Revenue ($m), USD Constant, Historic, 2007-2014
  • Table 33: Infectious Diagnostics Rapid Tests & POC Market, South Korea, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Table 34: Infectious Diagnostics Market, South Korea, Distribution Share by Revenue ($m), USD Constant, 2013-2014
  • Table 35: Infectious Diagnostics Market, South Korea, Company Share by Revenue ($m), USD Constant, 2014
  • Table 36: Infectious Diagnostics Market Pipeline Products

List of Figures

  • Figure 1: Infectious Diagnostics Market, Cross Country Comparison, Asia-Pacific, Revenue ($m), USD Constant, 2007-2021
  • Figure 2: Infectious Diagnostics Market, Asia-Pacific, Category Comparison by Revenue ($m), USD Constant, 2007-2021
  • Figure 3: Infectious Diagnostics Market, Asia-Pacific, Revenue ($m), Historic, USD Constant, 2007-2014
  • Figure 4: Infectious Diagnostics Market, Asia-Pacific, Revenue ($m), Forecast, USD Constant, 2014-2021
  • Figure 5: Infectious Diagnostics Market, Asia-Pacific, Company Share (%) 2014
  • Figure 6: Infectious Diagnostics Market, Australia, Revenue ($m), USD Constant, Historic, 2007-2014
  • Figure 7: Infectious Diagnostics Market, Australia, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Figure 8: Infectious Diagnostics Rapid Tests & POC Market, Australia, Revenue ($m), USD Constant, Historic, 2007-2014
  • Figure 9: Infectious Diagnostics Rapid Tests & POC Market, Australia, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Figure 10: Infectious Diagnostics Market, Australia, Company Share (%) 2014
  • Figure 11: Infectious Diagnostics Market, China, Revenue ($m), USD Constant, Historic, 2007-2014
  • Figure 12: Infectious Diagnostics Market, China, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Figure 13: Infectious Diagnostics Rapid Tests & POC Market, China, Revenue ($m), USD Constant, Historic, 2007-2014
  • Figure 14: Infectious Diagnostics Rapid Tests & POC Market, China, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Figure 15: Infectious Diagnostics Market, China, Company Share (%) 2014
  • Figure 16: Infectious Diagnostics Market, India, Revenue ($m), USD Constant, Historic, 2007-2014
  • Figure 17: Infectious Diagnostics Market, India, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Figure 18: Infectious Diagnostics Rapid Tests & POC Market, India, Revenue ($m), USD Constant, Historic, 2007-2014
  • Figure 19: Infectious Diagnostics Rapid Tests & POC Market, India, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Figure 20: Infectious Diagnostics Market, India, Company Share (%) 2014
  • Figure 21: Infectious Diagnostics Market, Japan, Revenue ($m), USD Constant, Historic, 2007-2014
  • Figure 22: Infectious Diagnostics Market, Japan, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Figure 23: Infectious Diagnostics Rapid Tests & POC Market, Japan, Revenue ($m), USD Constant, Historic, 2007-2014
  • Figure 24: Infectious Diagnostics Rapid Tests & POC Market, Japan, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Figure 25: Infectious Diagnostics Market, Japan, Company Share (%) 2014
  • Figure 26: Infectious Diagnostics Market, South Korea, Revenue ($m), USD Constant, Historic, 2007-2014
  • Figure 27: Infectious Diagnostics Market, South Korea, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Figure 28: Infectious Diagnostics Rapid Tests & POC Market, South Korea, Revenue ($m), USD Constant, Historic, 2007-2014
  • Figure 29: Infectious Diagnostics Rapid Tests & POC Market, South Korea, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Figure 30: Infectious Diagnostics Market, South Korea, Company Share (%) 2014
Back to Top